NovoLog
Sponsors
Nastech Pharmaceutical Company, Inc., University of Florida, Massachusetts General Hospital, Stanford University, Boston Medical Center
Conditions
Diabetes MellitusDiabetes Mellitus, Type 1PharmacodynamicsPharmacokineticsType 1 DiabetesType 1 Diabetes MellitusType 2 Diabetes Treated With Insulin
Phase 1
Phase 2
A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients
CompletedNCT00624767
Start: 2008-03-31End: 2008-05-31Updated: 2008-05-20
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
TerminatedNCT03262116
Start: 2019-03-19End: 2019-07-23Updated: 2022-12-09
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers
CompletedNCT05539872
Start: 2022-08-22End: 2023-01-30Updated: 2026-03-05